Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2427-2431

  Qu, Xian Jun ^a   Cui, Shu Xiang ^b   Tian, Zhigang ^a   Li, Xun ^a   Chen, Ming Hui ^a   Xu, Wen Fang ^a   Inagaki, Yoshinori ^c,d   Deng, Ying Bing ^d   Makuuchi, Masatoshi ^d   Nakata, Munehiro ^a,c   Tang, Wei ^a,d  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c TOKAI UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antineoplaston A10; Apoptosis; Hepatocellular carcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 PHENYLACETAMIDO 2,6 PIPERIDINEDIONE; DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CELL GROWTH; CELL MIGRATION; DOSE RESPONSE; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; XENOGRAFT;

ANIMALS; APOPTOSIS; BENZENEACETAMIDES; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHROMATIN; DNA, NEOPLASM; FEMALE; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; PIPERIDONES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34547793157     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Liau MC, Szopa M, Burzynski B and Burzynski SR: Chemosurveillance: a novel concept of the natural defence mechanism against cancer. Drugs Exp Clin Res 13: 71-76, 1987.
2. Badria F, Mabed M, Khafaqv W and Abou-Zeid L: Potential utility of antineoplaston A-10 levels in breast cancer. Cancer Lett 155: 67-70, 2000.
3. Burzynski SR: Antineoplastons: history of the research (I). Drugs Exp Clin Res 12(Suppl 1): 1-9, 1986.
4. Wang H, Xu W and Yuan Y: Studies of the release rate and bioavailability of antineoplaston A10 capsule. Drugs Exp Clin Res 16: 357-359, 1990.
5. Burzynski SR: The present state of antineoplaston research (1). Integr Cancer Ther 3: 47-58, 2004.
6. Qu X, Yuan Y, Xu W et al: Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloprotease activity. Anticancer Res 26: 3573-3578, 2006.
7. Qu XJ, Yang JL, Russell PJ and Goldstein D: Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. J Urol 172: 733-738, 2004.
8. Cui SX, Qu XJ, Xie YY et al: Curcumin inhibits telomerase activity in human cancer cell lines. Int J Mol Med 18: 227-231, 2006.
9. Lerma-Díaz JM, Hernández-Flores G, Domínguez- Rodríguez JR et al: In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IκBα phosphorylation. Immunol Lett 103: 149-158, 2006.
10. Sarkar FH and Li Y: Markers of apoptosis. Methods Mol Med 120: 147-160, 2006.
11. Han HS, Park YM and Hwang TS: Differential expression of Bcl-2, Bcl-XL and p53 in colorectal cancer. J Gastroenterol Hepatol 21: 1108-1114, 2006.
12. Qu XJ, Yuan YX, Tian ZG et al: Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis. Int J Mol Med 18: 609-614, 2006.
13. Soltysiak-Pawluczuk D and Burzynski SR: Cellular accumulation of antineoplaston AS21 in human hepatoma cells. Cancer Lett 88: 107-112, 1995.
14. Mates JM, Segura JA, Alonso FJ and Marques J: Pathways from glutamine to apoptosis. Front Biosci 11: 3164-3180, 2006.
15. Burzynski SR: Gene silencing - a new theory of aging. Med Hypotheses 60: 578-583, 2003.
16. Wang XW: Role of p53 and apoptosis in carcinogenesis. Anticancer Res 19: 4759-4771, 1999.
17. Kontopidis G, Wu SY, Zheleva DI et al: Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci USA 102: 1871-1876, 2005.
18. Zhao R, Xiang N, Domann FE and Zhong W: Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res 66: 2296-2304, 2006.
19. Russell M, Berardi P, Gong W and Riabowol K: Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Exp Cell Res 312: 951-961, 2006.
20. Badria F, Maben M, El-Awadi M et al: Immune modulatory potentials of antineoplaston A-10 in breast cancer patients. Cancer Lett 157: 57-63, 2000.